Polio Eradication Branch, Centers for Disease Control and Prevention, Atlanta, GA, USA.
Polio Eradication Branch, Centers for Disease Control and Prevention, Atlanta, GA, USA.
Vaccine. 2019 Mar 14;37(12):1577-1583. doi: 10.1016/j.vaccine.2019.02.008. Epub 2019 Feb 16.
Afghanistan remains among the three countries with endemic wild poliovirus transmission, and high population immunity levels are required to interrupt transmission and prevent outbreaks. Surveillance and vaccination of children in Afghanistan have been challenging due to security issues limiting accessibility in certain areas.
A serosurvey was conducted in 2013 within accessible enumeration areas (EAs) among children aged <5 years using samples collected for a national micronutrient assessment survey to assess poliovirus immunity in Afghanistan. Of 21194 total EAs in Afghanistan, 107 were inaccessible and therefore were excluded from the sampling frame.
Population immunity was high overall but varied for the poliovirus serotypes, and was lowest for type 3 (95% [95% CI: 93%, 96%]) compared to type 1 (99% [95% CI:97%, 99%]) and type 2 (98% [95% CI:96%, 99%]). The proportion of the population immune to all three types was 93% (95% CI: 91%, 95%), and the proportion seronegative for all three types was 0.5% (95% CI: 0.2%, 1.7%).
Except for regional differences in immunity to type 3 virus, there were no other apparent differences in seroprevalence by region or by any of the demographic or nutritional characteristics assessed in this study. The study was not powered to provide provincial level seroprevalence estimates, but Paktika Province, in the South region, had the largest proportion of seronegative specimens for type 1 (4 seronegative of 17 serum specimens compared to 14 seronegative of 673 for the remainder of the areas). Among accessible children in Afghanistan, seroprevalence of antibodies to poliovirus was high, with most seroprevalence reported at 95% or greater. Despite high seroprevalence in areas assessed in this study, the continued detection of poliovirus cases in the South and East regions indicate that overall regional vaccination coverage and performance is not sufficient to stop polio transmission.
阿富汗仍是三种野病毒脊髓灰质炎地方性传播国家之一,需要高人群免疫水平来阻断传播和防止暴发。由于安全问题限制了某些地区的可达性,阿富汗对儿童的监测和疫苗接种一直具有挑战性。
2013 年,在阿富汗可进入的普查区(EA)内,使用国家微量营养素评估调查收集的样本,对年龄<5 岁的儿童进行血清学调查,以评估阿富汗脊髓灰质炎病毒免疫力。在阿富汗的 21194 个总 EA 中,有 107 个无法进入,因此被排除在抽样框架之外。
总体而言,人群免疫力很高,但各型脊髓灰质炎病毒的免疫情况不同,3 型(95%[95%置信区间:93%,96%])的免疫力最低,1 型(99%[95%置信区间:97%,99%])和 2 型(98%[95%置信区间:96%,99%])。对所有三种类型均具有免疫力的人群比例为 93%(95%置信区间:91%,95%),对所有三种类型均为血清阴性的人群比例为 0.5%(95%置信区间:0.2%,1.7%)。
除 3 型病毒免疫方面存在区域差异外,本研究未评估地区或任何人口统计学或营养特征,按区域或任何人口统计学或营养特征评估,未发现血清阳性率的其他明显差异。本研究没有提供省级血清阳性率估计的能力,但在南部的帕克蒂卡省,1 型血清阴性的比例最大(17 份血清标本中有 4 份血清阴性,而其余地区的 673 份血清标本中有 14 份血清阴性)。在阿富汗可进入的儿童中,脊髓灰质炎病毒抗体的血清阳性率很高,大多数血清阳性率报告为 95%或更高。尽管本研究评估的地区血清阳性率较高,但南部和东部地区继续发现脊灰病毒病例表明,总体区域疫苗接种覆盖率和效果不足以阻止脊灰病毒传播。